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Background
To examine the interaction between B and T lympho-
cytes through the expression of CD40 and CD40
ligand (CD40L) and IgM levels in patients with
Ataxia-telangiectasia (AT).
Methods
Blood samples were obtained from 18 AT patients (from
the Federal University of Sao Paulo) and 8 age-sex-
matched controls (C) (one control per day test). Total
number of T, B, and NK cells were enumerated from
whole blood samples using TruCount Tubes. Peripheral
blood mononuclear cells (PBMC) were cryopreserved,
thawed and divided in two plates, one of them with
Phorbol myristate acetate (PMA) and Ionomycin to sti-
mulate cells in vitro. After 3 hours of stimulation, cells
were stained with conjugated monoclonal antibodies. In
the unstimulated tube: anti-CD19-PerCP, anti-CD3-
APCCy7, anti-CD8-FITC, anti-CD69-PECy7, anti-CD40-
APC, anti-CD40L-PE. In the stimulated tube: anti-CD3,
anti-CD8, anti-CD40, anti-CD40L. Events were analyzed
by flow cytometer (BD LSRFortessa), using FlowJo Soft-
ware. Linear association between IgM level and CD40
was measured via Pearson correlation. Statistical analysis
was performed with SPSS 20.0 and STATA 12, and a
significance threshold of <0.05 was used.
Results
• From 18 patients, 15 were male and 3 female, aged
from 5 to 25 years old. There were 3 pairs of sib-
lings. Consanguinity was present between 2 parents.
Ten of them are being treated with immunoglobulin
replacement therapy. One of them had recovered
from a neoplastic hematologic disease.
The total number of lymphocytes was reduced in AT
patients (928 - 4579 cel/mm3) compared to controls
(1646 – 6601 cel/mm3) (p=0.001). Total CD3+ (AT=
1163.8 cel/mm3; C= 2247.2 cel/mm3; p<0.001), CD4+
(AT= 531.4 cel/mm3; C= 1153.3 cel/mm3; p<0.001) and
CD8+ (AT= 507.6 cel/mm3; C= 880.3 cel/mm3; p=0.007)
numbers were decreased as well.
B cells counts also showed a reduction compared with
controls (AT= 118.7 cel/mm3; C= 649.3 cel/mm3;
p<0.001). By contrast, natural killer numbers were
increased (AT= 583.9 cel/mm3; C= 357.3 cel/mm3;
p=0.04).
Expression of CD40 was reduced compared with con-
trols (AT= 69.9%; range: 48.6 - 94; C= 87.4%; range:
83.1 – 96; p<0.001). It wasn’t found any significant sta-
tistical difference in CD40L expression between patients
and controls (p=0.616), despite having stimulation docu-
mented by CD69 expression as activation marker. We
found a tendency of Pearson correlation (r) between
CD40 and IgM (r=0.423; p=0.091), although it wasn’t
significant.
Conclusions
Patients with AT had lower expression of CD40 on sur-
face of B lymphocytes, which could induce abnormal
production of antibodies.
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